| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 1.26e-05 | 7 | 144 | 3 | GO:0008467 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity | 5.16e-05 | 2 | 144 | 2 | GO:0033872 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 9.00e-05 | 196 | 144 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 1.57e-04 | 15 | 144 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.77e-04 | 18 | 144 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 3.83e-04 | 20 | 144 | 3 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 3.83e-04 | 20 | 144 | 3 | GO:0005229 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 4.98e-04 | 51 | 144 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 MYO7B DYNC2H1 ABCA13 VPS4B CHD1 ATP8B1 DNAH14 ABCB1 MDN1 G3BP1 ABCA6 ATP1A1 | 5.13e-04 | 614 | 144 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | sulfotransferase activity | 6.65e-04 | 55 | 144 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC7A13 ABCA13 SLC19A2 BAK1 SLC39A13 ABCB1 SLCO1B7 PIEZO2 CLCA1 KCNU1 ABCA6 ANO6 SLC2A6 SLC20A1 SLC49A4 HRH1 ANO7 ATP1A1 SLC51A | 8.40e-04 | 1180 | 144 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC7A13 ABCA13 SLC19A2 BAK1 ATP8B1 SLC39A13 ABCB1 SLCO1B7 PIEZO2 CLCA1 KCNU1 ABCA6 ANO6 SLC2A6 SLC20A1 SLC49A4 HRH1 ANO7 ATP1A1 SLC51A | 9.61e-04 | 1289 | 144 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.05e-03 | 28 | 144 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | sterol ester esterase activity | 1.06e-03 | 7 | 144 | 2 | GO:0004771 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DYNC2H1 ABCA13 VPS4B CHD1 ATP8B1 ABCB1 MDN1 G3BP1 ABCA6 ATP1A1 | 1.38e-03 | 441 | 144 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 1.41e-03 | 8 | 144 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | nerve growth factor binding | 1.41e-03 | 8 | 144 | 2 | GO:0048406 | |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 1.80e-03 | 9 | 144 | 2 | GO:0045134 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.97e-03 | 180 | 144 | 6 | GO:0004866 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.02e-03 | 74 | 144 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 2.02e-03 | 74 | 144 | 4 | GO:0016782 | |
| Domain | A2M | 6.49e-07 | 10 | 142 | 4 | PF00207 | |
| Domain | A2M_N_2 | 6.49e-07 | 10 | 142 | 4 | IPR011625 | |
| Domain | A2M_comp | 6.49e-07 | 10 | 142 | 4 | IPR011626 | |
| Domain | A2M_recep | 6.49e-07 | 10 | 142 | 4 | PF07677 | |
| Domain | A2M_comp | 6.49e-07 | 10 | 142 | 4 | PF07678 | |
| Domain | A2M_N | 6.49e-07 | 10 | 142 | 4 | PF01835 | |
| Domain | A2M_N | 6.49e-07 | 10 | 142 | 4 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 6.49e-07 | 10 | 142 | 4 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 6.49e-07 | 10 | 142 | 4 | PS00477 | |
| Domain | A2M_N_2 | 6.49e-07 | 10 | 142 | 4 | PF07703 | |
| Domain | Macroglobln_a2 | 6.49e-07 | 10 | 142 | 4 | IPR001599 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 9.02e-06 | 18 | 142 | 4 | IPR008930 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 2.34e-05 | 8 | 142 | 3 | IPR019565 | |
| Domain | Thiol-ester_cl | 2.34e-05 | 8 | 142 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 2.34e-05 | 8 | 142 | 3 | IPR019742 | |
| Domain | DUF3548 | 5.74e-05 | 2 | 142 | 2 | IPR021935 | |
| Domain | DUF3548 | 5.74e-05 | 2 | 142 | 2 | PF12068 | |
| Domain | Dynein_HC_stalk | 1.47e-04 | 14 | 142 | 3 | IPR024743 | |
| Domain | MT | 1.47e-04 | 14 | 142 | 3 | PF12777 | |
| Domain | Sulfotransfer_1 | 1.56e-04 | 36 | 142 | 4 | PF00685 | |
| Domain | Sulfotransferase_dom | 1.56e-04 | 36 | 142 | 4 | IPR000863 | |
| Domain | Distal-less_N | 1.71e-04 | 3 | 142 | 2 | IPR022135 | |
| Domain | DLL_N | 1.71e-04 | 3 | 142 | 2 | PF12413 | |
| Domain | DHC_fam | 1.83e-04 | 15 | 142 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.83e-04 | 15 | 142 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.83e-04 | 15 | 142 | 3 | IPR004273 | |
| Domain | Lipase_GDXG_HIS_AS | 3.41e-04 | 4 | 142 | 2 | IPR002168 | |
| Domain | Lipase_GDXG_put_SER_AS | 3.41e-04 | 4 | 142 | 2 | IPR033140 | |
| Domain | - | DNHD1 MYO7B DYNC2H1 ABCA13 VPS4B CHD1 DNAH14 ABCB1 ARL10 MDN1 ABCA6 DSEL HS3ST4 HS3ST3B1 HS3ST3A1 | 5.64e-04 | 746 | 142 | 15 | 3.40.50.300 |
| Domain | Groucho_enhance | 5.65e-04 | 5 | 142 | 2 | IPR009146 | |
| Domain | Anaphylatoxin_comp_syst | 5.65e-04 | 5 | 142 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 5.65e-04 | 5 | 142 | 2 | IPR001840 | |
| Domain | TLE_N | 5.65e-04 | 5 | 142 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 5.65e-04 | 5 | 142 | 2 | IPR005617 | |
| Domain | AAA | 8.20e-04 | 144 | 142 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 8.20e-04 | 144 | 142 | 6 | IPR003593 | |
| Domain | LIPASE_GDXG_SER | 8.44e-04 | 6 | 142 | 2 | PS01174 | |
| Domain | LIPASE_GDXG_HIS | 8.44e-04 | 6 | 142 | 2 | PS01173 | |
| Domain | ANATO | 1.18e-03 | 7 | 142 | 2 | SM00104 | |
| Domain | Anoct_dimer | 1.18e-03 | 7 | 142 | 2 | PF16178 | |
| Domain | Anoct_dimer | 1.18e-03 | 7 | 142 | 2 | IPR032394 | |
| Domain | AlbA_2 | 1.18e-03 | 7 | 142 | 2 | PF04326 | |
| Domain | Schlafen | 1.18e-03 | 7 | 142 | 2 | IPR029684 | |
| Domain | ANAPHYLATOXIN_2 | 1.18e-03 | 7 | 142 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.18e-03 | 7 | 142 | 2 | PS01177 | |
| Domain | AB_hydrolase_3 | 1.18e-03 | 7 | 142 | 2 | IPR013094 | |
| Domain | Schlafen_AAA_dom | 1.18e-03 | 7 | 142 | 2 | IPR007421 | |
| Domain | Abhydrolase_3 | 1.18e-03 | 7 | 142 | 2 | PF07859 | |
| Domain | ANATO | 1.18e-03 | 7 | 142 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.18e-03 | 7 | 142 | 2 | IPR000020 | |
| Domain | GDA1_CD39_NTPase | 1.56e-03 | 8 | 142 | 2 | IPR000407 | |
| Domain | GDA1_CD39 | 1.56e-03 | 8 | 142 | 2 | PF01150 | |
| Domain | GDA1_CD39_NTPASE | 1.56e-03 | 8 | 142 | 2 | PS01238 | |
| Domain | A2M_N_2 | 1.56e-03 | 8 | 142 | 2 | SM01359 | |
| Domain | - | 1.56e-03 | 8 | 142 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 1.56e-03 | 8 | 142 | 2 | SM01361 | |
| Domain | A2M | 1.56e-03 | 8 | 142 | 2 | SM01360 | |
| Domain | P-loop_NTPase | DNHD1 MYO7B DYNC2H1 ABCA13 VPS4B CHD1 DNAH14 ABCB1 ARL10 MDN1 ABCA6 DSEL HS3ST4 HS3ST3B1 HS3ST3A1 | 2.03e-03 | 848 | 142 | 15 | IPR027417 |
| Domain | Anoctamin | 2.48e-03 | 10 | 142 | 2 | PF04547 | |
| Domain | Anoctamin | 2.48e-03 | 10 | 142 | 2 | IPR007632 | |
| Domain | ABC_A | 3.60e-03 | 12 | 142 | 2 | IPR026082 | |
| Domain | - | 3.60e-03 | 12 | 142 | 2 | 1.50.10.20 | |
| Domain | - | 4.24e-03 | 13 | 142 | 2 | 1.10.540.10 | |
| Domain | AcylCoA_DH/ox_N | 4.24e-03 | 13 | 142 | 2 | IPR013786 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.92e-03 | 14 | 142 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 4.92e-03 | 14 | 142 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.92e-03 | 14 | 142 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.92e-03 | 14 | 142 | 2 | IPR011704 | |
| Domain | AAA_8 | 4.92e-03 | 14 | 142 | 2 | PF12780 | |
| Domain | AAA_5 | 4.92e-03 | 14 | 142 | 2 | PF07728 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 5.65e-03 | 15 | 142 | 2 | IPR006091 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 5.65e-03 | 15 | 142 | 2 | IPR009100 | |
| Domain | Acyl-CoA_dh_M | 5.65e-03 | 15 | 142 | 2 | PF02770 | |
| Domain | ABC_tran | 5.80e-03 | 48 | 142 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.80e-03 | 48 | 142 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 6.14e-03 | 49 | 142 | 3 | PS00211 | |
| Domain | Sulfatase_CS | 6.42e-03 | 16 | 142 | 2 | IPR024607 | |
| Domain | AcylCo_DH/oxidase_C | 6.42e-03 | 16 | 142 | 2 | IPR009075 | |
| Domain | ABC_transporter-like | 6.50e-03 | 50 | 142 | 3 | IPR003439 | |
| Domain | SULFATASE_1 | 7.24e-03 | 17 | 142 | 2 | PS00523 | |
| Domain | C345C | 7.24e-03 | 17 | 142 | 2 | SM00643 | |
| Domain | SULFATASE_2 | 7.24e-03 | 17 | 142 | 2 | PS00149 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | RETREG2 DYNC2H1 DLGAP4 APOOL SLC19A2 ATP8B1 SORT1 USP8 MDN1 G3BP1 PTPRJ INTS2 XPO5 ANO6 SLC2A6 SLC20A1 ENTPD6 SEC23IP NCEH1 | 1.13e-07 | 1061 | 146 | 19 | 33845483 |
| Pubmed | Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice. | 2.89e-07 | 4 | 146 | 3 | 12421924 | |
| Pubmed | Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping. | 4.00e-06 | 8 | 146 | 3 | 30173917 | |
| Pubmed | 8.51e-06 | 10 | 146 | 3 | 30571765 | ||
| Pubmed | TICRR SLC7A13 SLFN12 GATA6 PSMD1 DIDO1 ALS2 STAT1 SLFN12L INTS2 BAZ1A SLC20A1 TLE4 SBF2 ENTPD6 PARD3 | 1.40e-05 | 1084 | 146 | 16 | 11544199 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.75e-05 | 2 | 146 | 2 | 16565498 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 15998580 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.75e-05 | 2 | 146 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.75e-05 | 2 | 146 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.75e-05 | 2 | 146 | 2 | 17645767 | |
| Pubmed | Mitochondrial Rab GAPs govern autophagosome biogenesis during mitophagy. | 1.75e-05 | 2 | 146 | 2 | 24569479 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.75e-05 | 2 | 146 | 2 | 27758680 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.75e-05 | 2 | 146 | 2 | 23749435 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.75e-05 | 2 | 146 | 2 | 3037333 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 11726230 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.75e-05 | 2 | 146 | 2 | 6950384 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 1692292 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.75e-05 | 2 | 146 | 2 | 8428773 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.75e-05 | 2 | 146 | 2 | 21345967 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 2572548 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 2302180 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 22475533 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.75e-05 | 2 | 146 | 2 | 18091514 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 29080553 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 30875077 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.75e-05 | 2 | 146 | 2 | 25339671 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 17728371 | ||
| Pubmed | Lack of reproducible growth inhibition by Schlafen1 and Schlafen2 in vitro. | 1.75e-05 | 2 | 146 | 2 | 18479948 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 6149580 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 6149581 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 12115608 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 3542363 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 2387317 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 16908004 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 7365238 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 7391573 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.75e-05 | 2 | 146 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.75e-05 | 2 | 146 | 2 | 17971229 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 6881182 | ||
| Pubmed | Absence of Nceh1 augments 25-hydroxycholesterol-induced ER stress and apoptosis in macrophages. | 1.75e-05 | 2 | 146 | 2 | 24891333 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.75e-05 | 2 | 146 | 2 | 17921792 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 1.75e-05 | 2 | 146 | 2 | 6978711 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 35898513 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 28873507 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 1.75e-05 | 2 | 146 | 2 | 6832377 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 3794341 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 11811950 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 21249125 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 22785613 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 1.75e-05 | 2 | 146 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 1.75e-05 | 2 | 146 | 2 | 3902619 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 20625037 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 1.75e-05 | 2 | 146 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 1.75e-05 | 2 | 146 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 1.75e-05 | 2 | 146 | 2 | 1357031 | |
| Pubmed | Temporospatial cell interactions regulating mandibular and maxillary arch patterning. | 1.75e-05 | 2 | 146 | 2 | 10603356 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 1.75e-05 | 2 | 146 | 2 | 16098595 | |
| Pubmed | Abrogation of neutral cholesterol ester hydrolytic activity causes adrenal enlargement. | 1.75e-05 | 2 | 146 | 2 | 21111707 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 1.75e-05 | 2 | 146 | 2 | 15787745 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 30026462 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 6559257 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 1.75e-05 | 2 | 146 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 1.75e-05 | 2 | 146 | 2 | 20506482 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 12480675 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 26800705 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 1.75e-05 | 2 | 146 | 2 | 15390104 | |
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 1.75e-05 | 2 | 146 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 1.75e-05 | 2 | 146 | 2 | 2997024 | |
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 1.75e-05 | 2 | 146 | 2 | 3624865 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 21857912 | ||
| Pubmed | A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. | 1.75e-05 | 2 | 146 | 2 | 10520990 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 1.75e-05 | 2 | 146 | 2 | 4514997 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 1.75e-05 | 2 | 146 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 1.75e-05 | 2 | 146 | 2 | 3167981 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 15304505 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 7545960 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 30041577 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 1.75e-05 | 2 | 146 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 1.75e-05 | 2 | 146 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 1.75e-05 | 2 | 146 | 2 | 18360261 | |
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 1.75e-05 | 2 | 146 | 2 | 26814963 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 8132550 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 2395880 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 26814708 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 6192448 | ||
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.09e-07 | 9 | 100 | 4 | 1234 | |
| GeneFamily | Solute carriers | SLC7A13 SLC25A34 SLC19A2 SLC39A13 SLCO1B7 SLC2A6 SLC20A1 SLC49A4 SLC51A | 3.42e-04 | 395 | 100 | 9 | 752 |
| GeneFamily | Schlafen family | 6.25e-04 | 7 | 100 | 2 | 1110 | |
| GeneFamily | Sulfotransferases, membrane bound | 1.11e-03 | 37 | 100 | 3 | 763 | |
| GeneFamily | Anoctamins | 1.32e-03 | 10 | 100 | 2 | 865 | |
| GeneFamily | ATP binding cassette subfamily A | 2.64e-03 | 14 | 100 | 2 | 805 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 1.83e-06 | 37 | 145 | 5 | MM630 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-09 | 184 | 145 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-09 | 184 | 145 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-09 | 184 | 145 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.14e-07 | 200 | 145 | 8 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-06 | 177 | 145 | 7 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.20e-06 | 181 | 145 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.28e-06 | 182 | 145 | 7 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-06 | 118 | 145 | 6 | 6053e19d040fb394f9c270361af07b0c5a4d47db | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-06 | 118 | 145 | 6 | 811e8521129914eef46785a4227c1860e77d9096 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-06 | 192 | 145 | 7 | 9479e9859140ba98abfe88414de0b28fc2bf43b7 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.47e-06 | 194 | 145 | 7 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.84e-06 | 197 | 145 | 7 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.84e-06 | 197 | 145 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.97e-06 | 198 | 145 | 7 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 3.97e-06 | 198 | 145 | 7 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 4.11e-06 | 199 | 145 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.25e-06 | 200 | 145 | 7 | 58c5870030192b337e7d883044948634fcd17d2c | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.25e-06 | 200 | 145 | 7 | 05486d86868f6a93429226063cca270f00dd8714 | |
| ToppCell | proximal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.25e-06 | 200 | 145 | 7 | 869d45b71efd395d050873db5fee2ed0443d5e6f | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 161 | 145 | 6 | 5c762609531a7c5505aa5637abf8e0311568d7fd | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 161 | 145 | 6 | b14a83ad07a7acb07c766aa862b527698976b6fc | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 161 | 145 | 6 | c5d9d47dcedfbb1ac77f4afaf860ae4d9f26fd3f | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 161 | 145 | 6 | 26c0d876339bfd34d9a43af5b9fb08f50526f2c9 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.53e-05 | 162 | 145 | 6 | 7c73fe8388af370461e04097cf145cbc9847285b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 168 | 145 | 6 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 2.01e-05 | 170 | 145 | 6 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-05 | 172 | 145 | 6 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-05 | 173 | 145 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 174 | 145 | 6 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 174 | 145 | 6 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 104 | 145 | 5 | fdf4599de8cd4ccf1bd7ede4e7af63d69c108b43 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 104 | 145 | 5 | a3d061170fe49d023ac31dbaeb2b5d2347988078 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.36e-05 | 175 | 145 | 6 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-05 | 176 | 145 | 6 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-05 | 176 | 145 | 6 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-05 | 176 | 145 | 6 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-05 | 176 | 145 | 6 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 177 | 145 | 6 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-05 | 177 | 145 | 6 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | COVID-19-Myeloid-MoAM4|Myeloid / Condition, Lineage and Cell class | 2.60e-05 | 178 | 145 | 6 | fe0017e6a1f23dc45f644b9acacc7e8aa80d0116 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.60e-05 | 178 | 145 | 6 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.77e-05 | 180 | 145 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-05 | 181 | 145 | 6 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.85e-05 | 181 | 145 | 6 | 8fcc9e77fee7c248df26b6c59b10e672242e2084 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.94e-05 | 182 | 145 | 6 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 182 | 145 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 182 | 145 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.04e-05 | 183 | 145 | 6 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-05 | 184 | 145 | 6 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.13e-05 | 184 | 145 | 6 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 185 | 145 | 6 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 185 | 145 | 6 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-05 | 185 | 145 | 6 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.23e-05 | 185 | 145 | 6 | 512f489daeb3b72d4578dc6f4d0ebb5f38d5bbab | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 3.23e-05 | 185 | 145 | 6 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.23e-05 | 185 | 145 | 6 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 3.33e-05 | 186 | 145 | 6 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.33e-05 | 186 | 145 | 6 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.43e-05 | 187 | 145 | 6 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 189 | 145 | 6 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 3.64e-05 | 189 | 145 | 6 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.64e-05 | 189 | 145 | 6 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 189 | 145 | 6 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.64e-05 | 189 | 145 | 6 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.75e-05 | 190 | 145 | 6 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.75e-05 | 190 | 145 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 3.86e-05 | 191 | 145 | 6 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-05 | 191 | 145 | 6 | 054e9a79bd1486fd812bc7418fb091664fe3a646 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 192 | 145 | 6 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 3.97e-05 | 192 | 145 | 6 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.97e-05 | 192 | 145 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-05 | 192 | 145 | 6 | d7faa993f68e530ad55185505384ae155d36c222 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.09e-05 | 193 | 145 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.09e-05 | 193 | 145 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 193 | 145 | 6 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 193 | 145 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 4.09e-05 | 193 | 145 | 6 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 193 | 145 | 6 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.09e-05 | 193 | 145 | 6 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 4.21e-05 | 194 | 145 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-05 | 194 | 145 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.21e-05 | 194 | 145 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-05 | 194 | 145 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.33e-05 | 195 | 145 | 6 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.33e-05 | 195 | 145 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 196 | 145 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.45e-05 | 196 | 145 | 6 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 197 | 145 | 6 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.58e-05 | 197 | 145 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.58e-05 | 197 | 145 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.58e-05 | 197 | 145 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.58e-05 | 197 | 145 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.58e-05 | 197 | 145 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.58e-05 | 197 | 145 | 6 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 4.58e-05 | 197 | 145 | 6 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.71e-05 | 198 | 145 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.85e-05 | 199 | 145 | 6 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.85e-05 | 199 | 145 | 6 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-05 | 199 | 145 | 6 | 36883044787a9fb79cf7e83a7da8e34eea83f2f1 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.98e-05 | 200 | 145 | 6 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| Drug | AC1L4GYE | 2.34e-08 | 6 | 145 | 4 | CID000156861 | |
| Disease | Colorectal Carcinoma | ABCA13 MCF2L2 CHD1 BRINP1 CSMD3 ABCB1 DEFA4 CD9 ABCA6 TLR2 PKHD1 HRH1 FLCN DSEL PZP | 1.34e-06 | 702 | 140 | 15 | C0009402 |
| Disease | renal cell carcinoma (is_implicated_in) | 1.97e-05 | 69 | 140 | 5 | DOID:4450 (is_implicated_in) | |
| Disease | Connective Tissue Diseases | 2.89e-05 | 13 | 140 | 3 | C0009782 | |
| Disease | Colorectal cancer | 2.81e-04 | 27 | 140 | 3 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 2.81e-04 | 27 | 140 | 3 | 114500 | |
| Disease | Neoplasm of the large intestine | 2.81e-04 | 27 | 140 | 3 | cv:C0009404 | |
| Disease | Colorectal Neoplasms | 3.70e-04 | 277 | 140 | 7 | C0009404 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.71e-04 | 128 | 140 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.71e-04 | 128 | 140 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.71e-04 | 128 | 140 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.71e-04 | 128 | 140 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.71e-04 | 128 | 140 | 5 | C0007134 | |
| Disease | Hereditary clear cell renal cell carcinoma | 4.62e-04 | 7 | 140 | 2 | C1333985 | |
| Disease | allergic rhinitis (is_implicated_in) | 6.14e-04 | 8 | 140 | 2 | DOID:4481 (is_implicated_in) | |
| Disease | age at initiation of corrective lens use | 6.14e-04 | 8 | 140 | 2 | EFO_0021781 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 7.19e-04 | 148 | 140 | 5 | C0279702 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.10e-04 | 152 | 140 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | ankylosing spondylitis | 9.42e-04 | 91 | 140 | 4 | EFO_0003898 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 1.20e-03 | 11 | 140 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | apolipoprotein B measurement | 1.29e-03 | 663 | 140 | 10 | EFO_0004615 | |
| Disease | total blood protein measurement | 1.41e-03 | 449 | 140 | 8 | EFO_0004536 | |
| Disease | rac GTPase-activating protein 1 measurement | 1.43e-03 | 12 | 140 | 2 | EFO_0801985 | |
| Disease | Liver Cirrhosis | 1.49e-03 | 103 | 140 | 4 | C0023890 | |
| Disease | sodium measurement | 1.49e-03 | 103 | 140 | 4 | EFO_0009282 | |
| Disease | Fibrosis, Liver | 1.60e-03 | 105 | 140 | 4 | C0239946 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.68e-03 | 13 | 140 | 2 | EFO_0800474 | |
| Disease | complement C4 measurement | 1.95e-03 | 52 | 140 | 3 | EFO_0004984 | |
| Disease | response to cisplatin, platinum measurement | 2.06e-03 | 53 | 140 | 3 | EFO_0010154, GO_0072718 | |
| Disease | brain volume measurement | 2.20e-03 | 595 | 140 | 9 | EFO_0006930 | |
| Disease | chronic lymphocytic leukemia | 2.53e-03 | 119 | 140 | 4 | EFO_0000095 | |
| Disease | colorectal cancer (is_implicated_in) | 2.69e-03 | 121 | 140 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | X-21441 measurement | 2.90e-03 | 17 | 140 | 2 | EFO_0800814 | |
| Disease | white matter hyperintensity measurement | 3.27e-03 | 302 | 140 | 6 | EFO_0005665 | |
| Disease | hypertension | 3.54e-03 | 307 | 140 | 6 | EFO_0000537 | |
| Disease | skin sensitivity to sun | 3.63e-03 | 19 | 140 | 2 | EFO_0004795 | |
| Disease | inferior parietal cortex volume measurement | 3.63e-03 | 19 | 140 | 2 | EFO_0010307 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 4.02e-03 | 20 | 140 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | schizophrenia (implicated_via_orthology) | 4.18e-03 | 68 | 140 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | breast size | 4.36e-03 | 69 | 140 | 3 | EFO_0004884 | |
| Disease | vitiligo (is_implicated_in) | 4.42e-03 | 21 | 140 | 2 | DOID:12306 (is_implicated_in) | |
| Disease | neutrophil percentage of granulocytes | 4.73e-03 | 228 | 140 | 5 | EFO_0007994 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FIWLTATKGHLSQIA | 196 | P60509 | |
| GASAWKSAFVATLPL | 251 | Q6UXG8 | |
| SSKWSAELAFSLPAL | 51 | Q9UJX2 | |
| ALTLALKSQFGSWGR | 121 | Q9P2K9 | |
| WGRTDSNFTSSLKKA | 466 | Q86XM0 | |
| KSGFTFWNLVFLLTV | 41 | Q7Z407 | |
| GLIWASSFFTLSLQK | 6 | P0C0L5 | |
| SRGSSTWLTAFVLKV | 1071 | P0C0L5 | |
| TLLLGNRWKTFFETV | 601 | O60477 | |
| FTLENFSKWRGSVLS | 271 | Q9UKQ2 | |
| FTKIATSLFESGINW | 111 | Q16611 | |
| SLALTAKSQVYSWGS | 571 | Q96Q42 | |
| TWIGASIVTSLSSFK | 341 | Q8TDY3 | |
| WKQFRALRSSGTAAA | 116 | Q2KHT4 | |
| KNAKSQLWISGLYTS | 1041 | Q8N139 | |
| VAKAGLASRWTNLGT | 431 | Q7Z5R6 | |
| STKSISFTRAQTGWL | 331 | Q8N6S4 | |
| LAKAIATFWGSLKNI | 2161 | Q86UQ4 | |
| KLWLTYSSQTTAILG | 276 | Q8N531 | |
| SAWQAYLSLSSTVLG | 4011 | Q96M86 | |
| FWKSSPSILAVQRSA | 86 | O14646 | |
| AASLGLTQTQVKIWF | 186 | Q07687 | |
| AASLGLTQTQVKIWF | 171 | P56178 | |
| GAIWKLDLSFSNITQ | 446 | Q96MT7 | |
| TNYVKRGSWSTLTLS | 286 | Q9Y2H0 | |
| RLDKFTGTLFWRNTS | 271 | O43520 | |
| QGNTWLTAFVLKTFA | 1036 | P01023 | |
| TKSALSAVASLAAAW | 516 | Q9NRL2 | |
| ILASFAGKNRVWVIS | 141 | Q76M96 | |
| WLTAFVLKTFAQARS | 1046 | P20742 | |
| STLNQAWATAKGALL | 451 | P78413 | |
| GLSAAVWAKILSSFT | 226 | P08183 | |
| AAAVLGSVLFILWKT | 16 | Q8N8L6 | |
| LKNRSSAFGTLNWFT | 151 | Q4KMQ2 | |
| SAFGTLNWFTKVLSV | 156 | Q4KMQ2 | |
| LLAAWASRIASLTGS | 536 | Q6IWH7 | |
| QKGSIWLSALTFKTL | 846 | Q6IE37 | |
| SKLTSALFNAASGWL | 336 | Q9H2M9 | |
| ALTGVRKAALSWSNG | 216 | Q12913 | |
| TSVGKTSLIQWLAAA | 1086 | Q9NU22 | |
| FKNRTAGLIDTSWSA | 256 | Q9Y662 | |
| ASKGAWLNRSSIIFA | 66 | Q7Z3B1 | |
| AWSVLTQRFKNGLFS | 451 | Q9NQZ7 | |
| TSFAWLLKACGSRLT | 256 | Q8NFG4 | |
| SQFLRGLLFGKSATW | 201 | P46439 | |
| SSAKFEAALTWILSS | 316 | Q8NC56 | |
| WLSFGHKFSQRSSLT | 1446 | Q86WG5 | |
| NSWKSLTSITLAGNL | 301 | Q86UE6 | |
| SKNLNSSFSISWLPF | 431 | Q6ZRQ5 | |
| WLEASFTAASLGKSV | 81 | Q8TC71 | |
| TLSTGKSVWLFNITA | 486 | Q5FYB0 | |
| TGSATVTAFWQSLLA | 256 | A6ND91 | |
| QSGVSFDKTSATWLA | 406 | P05023 | |
| SITNSKRGLFWFTLL | 116 | P0CG22 | |
| ISLFWKNLSVSEARG | 341 | Q99665 | |
| WSSVKASLTRIAVAF | 111 | Q86YR7 | |
| ASAVTASTGLLWKRA | 41 | Q9BPX6 | |
| IVSFGKKSAWSSAQV | 66 | Q6PIU2 | |
| KAASWRGQSLGSLYT | 216 | Q92817 | |
| LLGTNAKVRTWFGTF | 306 | Q9H0H0 | |
| FKNRTAGLIDTSWSA | 271 | Q9Y663 | |
| KLLSIILSTWFTAAG | 226 | A8MYU2 | |
| WNAKKTGSISFDFRT | 496 | Q9ULB1 | |
| GQSFLLSRQAKVATW | 31 | Q9P1G2 | |
| LTKSQASWFGSVFTL | 76 | Q9UGQ3 | |
| VFSAKGIVLALVSTW | 131 | Q9NQS5 | |
| LKSSFLRGLGSWKSN | 21 | Q6MZN7 | |
| FILATGSADKTVALW | 286 | Q16576 | |
| FILAVTLTLWSSGKV | 11 | P61366 | |
| STALWINTFLGVSTL | 216 | Q86UW1 | |
| GTVLLWANKFRFSTD | 216 | Q5VZV1 | |
| RSNKFSIKSDVWSFG | 406 | P42685 | |
| AATASKLLWSSRGAK | 121 | Q92908 | |
| LDKWGTSTLVAFLQQ | 2366 | Q8NCM8 | |
| HALTAGLKAFTSWTA | 371 | Q15067 | |
| IGLWLRFDSQTKSIF | 31 | P21926 | |
| SSFLSAHKLSGLWNS | 196 | Q96PV7 | |
| LLLFSGATLSSTWFT | 351 | Q96SL1 | |
| LRTFSWASVTSKNLP | 246 | Q13283 | |
| TTLFLSRLSTIWKGF | 1046 | Q9BTC0 | |
| NWATAKLLLSETGFL | 2391 | Q0VDD8 | |
| TAALKSSGLWNNTVF | 281 | P15848 | |
| KTRASATILGAWFLS | 141 | P35367 | |
| ASEVRAWLQAKGFSS | 636 | Q8TE68 | |
| LVSGSADFTVKVWAL | 241 | Q9UKT8 | |
| FAWDKSSALQVSGST | 46 | P12838 | |
| TSFKSVLRGWSNPTI | 71 | P60507 | |
| SVAGWSLFSLNVISL | 181 | O60779 | |
| FGSAVWQLVASFLKL | 111 | Q8WUM9 | |
| RWSAAKLQLSTALGG | 276 | Q96H72 | |
| VLSLSSGSWTLKLHF | 1001 | Q8IZU8 | |
| LLAVTATGLAFGTWK | 221 | Q86T03 | |
| FKNRTLGLIDASWSA | 316 | Q9Y661 | |
| GLIWASSFFTLSLQK | 6 | P0C0L4 | |
| FSGNKTCLSLWTARI | 526 | O14772 | |
| SWLNSFLELSGRKSQ | 826 | Q05469 | |
| FTKLWSALNLSISVH | 31 | Q8N323 | |
| SGFSNSVLQSTWTLK | 151 | Q9GZK3 | |
| TRWSTTAGFLKQNTA | 171 | Q8TEW0 | |
| TSQQIFGAVKSLWTK | 171 | Q6UXV4 | |
| EWNFTASSIKGISLS | 571 | Q6ZN16 | |
| GWRKSSINLFVTNLA | 111 | Q9NSD7 | |
| GIKWRFIATSSASQL | 21 | Q9NYK5 | |
| LALSTENGLWVSKNF | 231 | Q99523 | |
| ATSLTLLTVAAGWLF | 356 | Q9BTV4 | |
| VLSWQFSSVTKRGLN | 501 | P42224 | |
| AAFSGNQWILSKLLD | 96 | Q8IWB6 | |
| SAAQLATFASAKAWV | 181 | Q6PIV7 | |
| VSAWITINFLTGSLK | 226 | O75354 | |
| WKTSRATGTAFLLLA | 16 | Q9NPC1 | |
| AAALNGLFWLLSSSS | 86 | Q8NC44 | |
| ATNWAKFTATASLGV | 396 | Q99460 | |
| TLTGLSLTQVSNWFK | 236 | Q8N196 | |
| FSNVSAGSWIISSTL | 3006 | P08F94 | |
| KQGFISSLKSAWQTL | 871 | Q9Y6Y8 | |
| GWSASKTNFLLGVLA | 321 | G3V0H7 | |
| AKWLQSSIFSGGLQT | 61 | Q9BVR0 | |
| KTGELNAFLSLKNWT | 531 | Q6NSI8 | |
| SKLWISNGGLADIFT | 246 | P49748 | |
| VGTWKYSLQASSQTL | 561 | A8K7I4 | |
| FFSISSSDLVSKWLG | 196 | O75351 | |
| FTLSGKWLSPTQLSA | 91 | Q9UBS8 | |
| KIAWFLVTSANLSKA | 506 | Q9NUW8 | |
| LVTSANLSKAAWGAL | 511 | Q9NUW8 | |
| SWAFSVSLGELKSIR | 116 | Q9HA65 | |
| ALLATGQWKSITLFV | 146 | P07996 | |
| FLKGSVAQWSLPTSS | 341 | Q7Z2Z1 | |
| AFSVTSWASLATLAL | 161 | A6NGC4 | |
| VNKGSLIFSRSWSLD | 436 | Q6IEE8 | |
| FVSTGKDNLLNAWRT | 716 | Q04727 | |
| VFSWSIQRNLSLGAK | 2531 | Q9H5I5 | |
| DFISKIQSLGFWTRL | 746 | Q6P2S7 | |
| ADAVTWLFTSVLKGL | 1066 | Q9HAV4 | |
| FVKSWSLNTSGLRIT | 106 | Q8IYM2 | |
| VKAFNTISAWALQSG | 131 | Q687X5 | |
| AESKFSGNIKNWTSL | 2301 | Q709C8 | |
| AQLLGSWTYTKTVSR | 136 | P08922 | |
| VNAISTGNWSLKRFK | 416 | Q9NW08 | |
| GTASATKWAFVLASA | 1116 | O15040 | |
| TVAFLNLWTSLFLGS | 91 | Q8TCU3 | |
| NGKSKWSFLFSLTDL | 121 | Q8TC07 | |
| QTWVATNTLSKAAFL | 826 | A7E2V4 | |
| SLQLASQRGSWSGKL | 1426 | Q6PGP7 | |
| KFASFLLGSWVLSAL | 91 | Q8NBM4 | |
| LASWVSGKFSSLLQA | 176 | Q6PJ69 | |
| FVSTGKDNLLNAWRT | 686 | Q04725 | |
| SSSWFKPLSSLTFLN | 116 | O60603 | |
| WFSSAKDLQIGTTLR | 261 | P40818 | |
| LSAKKASTLWRATGN | 691 | Q9P275 | |
| KLFVLSFGTNAGSLW | 206 | A6NCI4 | |
| SLLAGTSVSRFWIFS | 181 | P57075 | |
| NFKTSSLARGWILLS | 1121 | Q6PIF6 |